Full Text Journal Articles in
Journal Urol Oncol

Advertisement

Find full text journal articles






Methodological considerations for systematic review and meta-analysis of Xpert bladder cancer monitor.

Cho-Han Chiang, Cho-Hsien Chiang, Cho-Hung Chiang,

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma.

Zeynep B Zengin, Alex Chehrazi-Raffle, Nicholas J Salgia, Ramya Muddasani, Sana Ali, Luis Meza, Sumanta K Pal,

The management of urothelial carcinoma (UC) has rapidly advanced in recent years with new approvals for immune checkpoint inhibitors and antibody-drug conjugates. However, while many UC tumors contain potentially actionable mutations, the role for targeted small molecule inhibitors has been limited. One such target is the fibroblast growth factor receptor ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Bladder Cancer (NMIBC) in a population-based cohort from Stockholm County with long-term follow-up; A comparative analysis of prediction models for recurrence and progression, including external validation of the updated 2021 E.A.U. model.

Zachary Dovey, John Pfail, Alberto Martini, Gunnar Steineck, Linda Dey, Lotta Renström, Abolfazl Hosseini, John P Sfakianos, Peter Wiklund,

<h4>Introduction</h4>Non muscle invasive bladder cancer (NMIBC) has recurrence and progression rates of approximately 55-75% and 5-45% respectively. After diagnosis, risk stratification guides management decisions regarding surveillance, intravesical therapy or surgery. This prospective cohort of patients from Stockholm County is ideal for external validation of the current risk stratification models used ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Simplified PADUA renal (SPARE) nephrometry score validation and long-term outcomes after robot-assisted partial nephrectomy.

Giuseppe Rosiello, Pietro Piazza, Stefano Puliatti, Elio Mazzone, Marco Amato, Victor Tames, Rui Farinha, Ruben De Groote, Camille Berquin, Dries Develtere, Celine Sinatti, Alessandro Larcher, Umberto Capitanio, Frederiek D'Hondt, Peter Schatteman, Alberto Briganti, Francesco Montorsi, Geert De Naeyer, Alexandre Mottrie,

<h4>Background</h4>International guidelines suggest the use of anatomic scores to predict surgical outcomes after partial nephrectomy (PN). We aimed at validating the use of Simplified PADUA Renal (SPARE) nephrometry score in robot-assisted PN (RAPN).<h4>Materials and methods</h4>Three hundred and sixty-eight consecutive RAPN patients were included. Primary endpoints were overall complications, postoperative acute ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): A single institution series.

Ragheed Saoud, Tanya W Kristof, Clark Judge, Vaibhav Chumbalkar, Tatjana Antic, Scott Eggener, Parth Modi,

Renal angiomyolipomas are benign tumors of the kidney that belong to the 'PEComa: perivascular epithelioid cell' family. Epithelioid AMLs (eAML) are a rare monotypic subtype with malignant potential, that can occur sporadically or be associated with tuberous sclerosis (TSC). Due to their epithelioid nature, eAMLs can closely resemble high-grade renal cell ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints.

Giuseppe Basile, Marco Bandini, Daniele Raggi, Laura Marandino, Filippo Pederzoli, Andrea Salonia, Alberto Briganti, Francesco Montorsi, Sanjay B Kulkarni, Andrea Necchi,

Radical cystectomy is the standard of care for muscle invasive bladder cancer, although it represents a surgical procedure with high complication and mortality burden. Thus, more and more emphasis has been placed in favor of alternative treatments especially for patients who are unfit for or aim to avoid radical cystectomy. ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Validating the Association of Adverse Pathology with Distant Metastasis and Prostate Cancer Mortality 20-Years After Radical Prostatectomy.

Michael A Brooks, Lewis Thomas, Cristina Magi-Galluzzi, Jianbo Li, Michael R Crager, Ruixiao Lu, Frederick L Baehner, John Abran, Tamer Aboushwareb, Eric A Klein,

<h4>Purpose</h4>To assess the association of adverse pathology (AP), defined as high-grade (≥ Gleason Grade Group 3) and/or non-organ confined disease, with long-term oncologic outcomes after radical prostatectomy (RP).<h4>Materials and methods</h4>Using a stratified cohort sampling design, we evaluated the association of AP with the risk of distant metastasis (DM) and prostate ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Subsequent primary urogenital cancers among childhood and adolescent cancer survivors in the United States.

Jason J Liu, Immaculata De Vivo, Chun-Ying Wu, Edward Giovannucci,

<h4>Purpose</h4>To conduct an updated and comprehensive study on the risks of subsequent primary urogenital cancers for childhood and adolescent cancer survivors.<h4>Methods</h4>This longitudinal study was conducted using 9 cancer registries from the Surveillance, Epidemiology and End Results (SEER) Program with follow-up from 1975 to 2017. There were 43,991 patients diagnosed with ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomy.

Nico C Grossmann, Victor M Schuettfort, Benjamin Pradere, Pawel Rajwa, Fahad Quhal, Hadi Mostafaei, Ekaterina Laukhtina, Keiichiro Mori, Reza S Motlagh, Abdulmajeed Aydh, Satoshi Katayama, Marco Moschini, Christian D Fankhauser, Thomas Hermanns, Mohammad Abufaraj, Dong-Ho Mun, Kristin Zimmermann, Harun Fajkovic, Martin Haydter, Shahrokh F Shariat,

<h4>Purpose</h4>To investigate the predictive and prognostic value of the preoperative systemic immune-inflammation index (SII) in patients undergoing radical cystectomy (RC) for clinically non-metastatic urothelial cancer of the bladder (UCB).<h4>Methods</h4>Overall, 4,335 patients were included, and the cohort was stratified in two groups according to SII using an optimal cut-off determined by ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Sex difference in survival in patients with radical cystectomy.

Tomoyuki Kawada,

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Critical shortage in BCG immunotherapy: How did we get here and where will it take us?

Michael Harvey, Bodie Chislett, Marlon Perera, Nathan Lawrentschuk, Damien Bolton, Gregory Jack,

Intravesical Bacillus Calmette-Guérin vaccine, one of the most successful bio-therapies to date, has been the gold standard treatment for non-muscle invasive bladder cancer for 44 years. International shortages have necessitated rationing this life-saving medication with deleterious effects on the primary treatment of high-grade non-muscle invasive bladder cancer. Understanding the history ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Collecting duct carcinoma: A single-institution retrospective study.

Zhuoer Xie, Siddhartha Yadav, Christine M Lohse, John C Cheville, Lance C Pagliaro, Paras H Shah, Stephen A Boorjian, Houston Thompson, Bradley C Leibovich, Brian A Costello,

<h4>Purpose</h4>Collecting duct carcinoma is a rare pathologic entity with a paucity of clinical data in the literature. We aim to evaluate our institutional experience with the management of this disease.<h4>Materials and methods</h4>All renal tumors in the Mayo Clinic Nephrectomy Registry were re-reviewed retrospectively by an expert urologic pathologist. Cases of ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Increasing the value of PSA through improved implementation.

Suzanne Lange, Brock O'Neil,

Low-value testing and treatment contribute to billions of dollars in waste to the United States health care system annually. High frequency, low-cost testing, including prostate-specific antigen (PSA) testing, is a major contributor to this inefficient health care delivery. Despite decreasing mortality of prostate cancer over the last few decades, the ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen.

Nicholas W Eyrich, John T Wei, Yashar S Niknafs, Javed Siddiqui, Chad Ellimoottil, Simpa S Salami, Ganesh S Palapattu, Rohit Mehra, Lakshmi P Kunju, Scott A Tomlins, Arul M Chinnaiyan, Todd M Morgan, Jeffrey J Tosoian,

<h4>Background</h4>To evaluate the association between urinary MyProstateScore (MPS) and pathologic grade group (GG) at surgery in men diagnosed with GG1 prostate cancer (PCa) on biopsy.<h4>Methods</h4>Using an institutional biospecimen protocol, we identified men with GG1 PCa on biopsy and PSA ≤10 ng/ml who underwent radical prostatectomy (RP) at the University of ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Plasmacytoid urothelial carcinoma of the bladder: MRI features and their association with survival.

Sungmin Woo, Soleen Ghafoor, Jeeban P Das, Natalie Gangai, Alvin C Goh, Herbert Alberto Vargas,

<h4>Objectives</h4>Plasmacytoid urothelial carcinomas (PUC) of the bladder are rare variants known for diffuse and infiltrative spread, however their magnetic resonance imaging (MRI) features are not well established. We aimed to evaluate MRI features of PUC of the bladder and their association with survival.<h4>Methods and materials</h4>This retrospective single-center study included 41 ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside.

Che Hsueh Yang, Wei Chun Weng, Yen Chuan Ou, Yi Sheng Lin, Li Hua Huang, Chin Heng Lu, Tang Yi Tsao, Chao Yu Hsu, Min Che Tung,

<h4>Objectives</h4>This study aimed to determine the prognostic values of Ki67 and vimentin in upper tract urothelial carcinoma (UTUC) after extirpative surgery.<h4>Methods and materials</h4>Between 2014 and 2019, patients diagnosed with UTUC and receiving radical nephroureterectomy were included retrospectively. Nuclear MIB-1 clones and cytoplasmic VIM 3B4 clones were used to assess Ki67 ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Evaluating health-related quality of life as a prognostic tool for overall survival in routine cancer care for older patients with bladder cancer: A US based study.

Ambrish A Pandit, Naleen Raj Bhandari, Mahmoud I Khalil, Mohamed H Kamel, Rodney Davis, Nalin Payakachat,

<h4>Purpose</h4>Health-related quality of life (HRQoL) outcomes, in addition to being useful for monitoring a person's health and well-being, may also predict overall survival (OS) in cancer patients. This study's objective was to examine the association of longitudinally assessed HRQoL and OS in patients with a history of bladder cancer (BC).<h4>Materials ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Defining radical cystectomy using the ICD-10 procedure coding system.

Timothy D Lyon, Kassem S Faraj, Emily Brennan, Mark D Tyson, Stephen A Boorjian, Aaron C Spaulding,

<h4>Introduction</h4>The International Classification of Diseases-10-Procedure Coding System (ICD-10-PCS) is markedly more complex than the preceding ICD-9 system, which has increased the difficulty of identifying radical cystectomy (RC) in administrative datasets. Given the absence of a consensus code definition for RC, we sought to develop and internally validate a list of ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Comparative study of postoperative complications after radical cystectomy during the past two decades in Japan: Radical cystectomy remains associated with significant postoperative morbidities.

Shuhei Yamada, Takashige Abe, Ataru Sazawa, Hidenori Katano, Hidetaka Suzuki, Ichiro Takeuchi, Junji Ishizaki, Keita Minami, Ken Morita, Kunihiko Tsuchiya, Norikata Takada, Shintaro Maru, Shuhei Ishikawa, Soshu Sato, Takafumi Kawazu, Takanori Yamashita, Takenori Ono, Tango Mochizuki, Tomoshige Akino, Yoshihiro Sasaki, Yuichiro Shinno, Jun Furumido, Haruka Miyata, Hiroshi Kikuchi, Ryuji Matsumoto, Takahiro Osawa, Nobuo Shinohara,

<h4>Objectives</h4>During the past 2 decades, in order to improve perioperative and oncological outcomes, a minimally invasive approach, neoadjuvant chemotherapy (NAC), and an enhanced postoperative recovery program after surgery have been introduced into routine clinical practice of radical cystectomy (RC). Our aim was to examine the differences in clinical practice and ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series.

Francesco Barletta, Armando Stabile, Elio Mazzone, Giorgio Brembilla, Gabriele Sorce, Francesco Pellegrino, Simone Scuderi, Donato Cannoletta, Giuseppe Ottone Cirulli, Vito Cucchiara, Giorgio Gandaglia, Francesco De Cobelli, Francesco Montorsi, Alberto Briganti,

<h4>Objective</h4>We aimed at optimizing the follow-up for patients with a positive multiparametric magnetic resonance of the prostate (mpMRI) and a subsequent negative targeted biopsy (TBx) plus systematic biopsy (SBx).<h4>Materials and methods</h4>A total of 308 men with a clinical suspicion of PCa and a positive mpMRI (PI-RADS ≥ 3) with concomitant ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Efficacy of nivolumab plus ipilimumab as first-line therapy for primary tumors in patients with renal cell carcinoma.

Hiroshi Kikuchi, Takahiro Osawa, Ryuji Matsumoto, Takashige Abe, Satoru Maruyama, Toru Harabayashi, Haruka Miyata, Akira Kashiwagi, Suguru Ikeshiro, Ataru Sazawa, Riyo Fukui, Ken Morita, Ichiro Takeuchi, Kanta Hori, Noboru Yamashita, Keita Minami, Tango Mochizuki, Sachiyo Murai, Nobuo Shinohara,

<h4>Objectives</h4>With the emergence of several effective combination therapies, information on their effects at the primary site will be crucial for planning future cytoreductive nephrectomy (CN). The present study focused exclusively on changes in primary tumor sizes following treatment with nivolumab plus ipilimumab and investigated the clinical factors associated with a ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Validation of testicular germ cell tumor staging in nationwide cancer registries.

Rohit R Badia, Daniel Wong, Rashed Ghandour, Nathan Chertack, Xiaosong Meng, Ryan Hutchinson, Vitaly Margulis, Yair Lotan, Alejandra Madrigales, Solomon Woldu, Aditya Bagrodia,

<h4>Introduction</h4>Nationwide cancer registries such as the National Cancer Database and Surveillance, Epidemiology, and End Results rely on accurate data from tumor registries to formulate hypotheses and report outcomes and treatment patterns. We evaluated the accuracy of our institutional registry for testicular germ cell tumors by comparing data abstracted by urologists ... Read more >>

Urol Oncol (Urologic oncology)
[2021, 39(12):838.e1-838.e6]

Cited: 0 times

View full text PDF listing >>



Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.

Rocco Simone Flammia, Francesco Chierigo, Christoph Würnschimmel, Benedikt Horlemann, Benedikt Hoeh, Gabriele Sorce, Zhen Tian, Costantino Leonardo, Derya Tilki, Carlo Terrone, Fred Saad, Shahrokh F Shariat, Francesco Montorsi, Felix Kh Chun, Michele Gallucci, Pierre I Karakiewicz,

<h4>Background</h4>We relied on the most contemporary Surveillance, Epidemiology, and End Results (SEER) database and tested the hypothesis that chemotherapy may improve survival in metastatic urachal carcinoma (m-UraC).<h4>Material and methods</h4>Within the SEER database (2004-2016), we identified m-UraC patients aged ≥ 18 years. Propensity score matching (PSM: cystectomy status, age and sex), ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Association between prior nephrectomy and efficacy of immune checkpoint inhibitor therapy in metastatic renal cell carcinoma - A systematic review and meta-analysis.

Raj Satkunasivam, Jonathan Ca Guzman, Zachary Klaassen, Mary E Hall, Amy N Luckenbaugh, Kelvin Lim, Aaron A Laviana, Antonio P DeRosa, Kathryn E Beckermann, Brian Rini, Christopher Jd Wallis,

<h4>Background</h4>Immune checkpoint-inhibitor (ICI)-based therapy is the standard of care for first-line treatment of metastatic renal cell carcinoma (mRCC). It is unclear whether prior removal of the primary tumor influences the efficacy of these treatments. We performed a systematic review and meta-analysis of studies of first-line ICI in mRCC to determine ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative.

Benjamin Shiff, Rodney H Breau, Ranjeeta Mallick, Frédéric Pouliot, Alan So, Simon Tanguay, Anil Kapoor, Jean-Baptiste Lattouf, Luke Lavallée, Adrian Fairey, Antonio Finelli, Bimal Bhindi, Jun Kawakami, Ricardo Rendon, Rahul K Bansal,

<h4>Purpose</h4>The prognostic significance of level of venous tumor thrombus (VTT) extension in patients with non-metastatic renal cell carcinoma (RCC) has been controversial. The aim of this study was to examine the prognostic significance of VTT extent in patients who underwent surgery for non-metastatic RCC.<h4>Materials and methods</h4>The Canadian Kidney Cancer information ... Read more >>

Urol Oncol (Urologic oncology)
[2021, 39(12):836.e19-836.e27]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

1.2089 s